Gold retreated to $1633 by the start of this month, close to the lows of September and October, but gained about 1% surpassing $1650. We saw a similar buying spree the month before, and such Read more…
AUD/USD has put the brakes on a 3-day slide today and has posted sharp gains. In the European session, the Australian dollar is trading at 0.6449, up 0.81%. RBA delivers modest 0.25% hike As was Read more…
Daily Pivots: (S1) 0.9849; (P) 0.9908; (R1) 0.9942; More… Intraday bias in EUR/USD stays neutral and outlook is unchanged. Further rise is in favor as long as 0.9847 minor support holds. Break of 1.0092 will Read more…
Daily Pivots: (S1) 0.9972; (P) 1.0003; (R1) 1.0047; More… Intraday bias in USD/CHF remains neutral for the moment. On the upside, break of 1.0030 minor resistance will suggest that pull back from 1.0146 has completed Read more…
Solid earnings, a big healthcare deal and bets on a Fed pivot have stocks looking to kick-off the first day of November trading firmly in the green. U.S. equity futures resumed their recent climb Tuesday, Read more…
Daily Pivots: (S1) 147.92; (P) 148.38; (R1) 149.22; More… USD/JPY is extending the corrective pattern from 151.93 and outlook is unchanged. Deeper decline cannot be ruled out, but downside should be contained by 38.2% retracement Read more…
The firm recently unveiled a vast restructuring plan including the elimination of 9,000 jobs by 2025. Doubt still hangs over Credit Suisse like a shadow that is difficult to shake off. The 166-year old bank unveiled Read more…
Illustration: The Verge Google’s rolling out a handful of new shopping features that should make it easier to find good deals directly from search. When you search for a product, Google will now surface results Read more…
“The addition of Abiomed is an important step in our vision for the new Johnson & Johnson focused on Pharmaceutical and MedTech,” said CEO Joaquin Duato. Abiomed (ABMD) – Get ABIOMED Inc. Report shares rocketed higher Read more…
Daily Pivots: (S1) 1.1414; (P) 1.1514; (R1) 1.1567; More… Intraday bias in GBP./USD stays neutral and outlook is unchanged. Consolidation from 1.1664 could extend but overall, further rise is expected as long as 1.1256 minor Read more…